Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA removes Boxed Warning about risk of leg and foot amputations for the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) FDA We have received an uptick in questions related to this substance. We felt it was best to share our policy here to bring attention to it. . OCB adheres to WADA guidelines FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News May 19, 2025: Investigations raise questions about product safety at a Texas compounding company Partnership for Safe Medicines